During the past decade, Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital" are "Low Back Pain" (2 trials), "Chronic Pain" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital" in a lesser frequency.

Most popular intervention types in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Tanezumab 5 mg" (2 trials), "Celecoxib" (1 trials), "NSAID" (1 trials), "Placebo for celecoxib" (1 trials) and "Placebo for tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kohno Clinical Medicine Research Institute Daisan Kitashinagawa Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".